Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

LGND Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.90%

Insider Buying (Last 12 Months): $243,475.00

Insider Selling (Last 12 Months): $7,559,608.80

Ligand Pharmaceuticals Insider Trading History Chart

Ligand Pharmaceuticals Share Price & Price History

^$111.56

▼ -0.24 (-0.21%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

Ligand Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/23/2024	Andrew Reardon	Insider	Sell	2,000	$99.60	$199,200.00	22,534
9/23/2024	Matthew E Korenberg	COO	Sell	9,772	$101.22	$989,121.84	50,777
9/20/2024	Matthew E Korenberg	COO	Sell	6,275	$104.10	$653,227.50	50,777
9/20/2024	Octavio Espinoza	CFO	Sell	1,275	$103.94	$132,523.50	24,610
8/28/2024	Andrew Reardon	Insider	Sell	1,500	$106.39	$159,585.00	22,534
8/26/2024	Matthew E Korenberg	COO	Sell	11,389	$105.61	$1,202,792.29	49,510
8/22/2024	Matthew E Korenberg	COO	Sell	1,157	$105.54	$122,109.78	67,211
8/9/2024	Matthew E Korenberg	COO	Sell	18,245	$98.50	$1,797,132.50	68,368
8/8/2024	Todd C Davis	CEO	Buy	2,500	$97.39	$243,475.00	123,010
5/17/2024	Octavio Espinoza	CFO	Sell	5,156	$86.66	$446,818.96	23,379
5/15/2024	Octavio Espinoza	CFO	Sell	5,873	$86.01	$505,136.73	23,882
5/13/2024	Matthew E Korenberg	Insider	Sell	3,440	$84.54	$290,817.60	100,421
5/9/2024	Andrew Reardon	Insider	Sell	10,000	$83.04	$830,400.00	22,205
5/9/2024	Nancy Ryan Gray	Director	Sell	934	$83.20	$77,708.80	5,633
3/5/2024	Stephen L Sabba	Director	Sell	1,893	$74.30	$140,649.90	28,926
2/28/2024	Octavio Espinoza	CFO	Sell	140	$88.46	$12,384.40	29,755
9/22/2023	Todd C Davis	CEO	Buy	4,000	$59.38	$237,520.00	73,090
5/16/2023	John W Kozarich	Director	Sell	4,444	$77.20	$343,076.80	38,488
5/10/2023	Stephen L Sabba	Director	Sell	6,408	$77.13	$494,249.04	25,784
5/8/2023	John W Kozarich	Director	Sell	6,408	$76.56	$490,596.48	42,213
3/24/2023	Andrew Reardon	Insider	Sell	300	$69.92	$20,976.00	16,308
12/16/2022	John L. Higgins	Director	Sell	10,000	$61.87	$618,700.00	422,984
11/17/2022	John L. Higgins	CEO	Sell	10,000	$78.32	$783,200.00	416,731
11/9/2022	Octavio Espinoza	CFO	Sell	1,696	$75.64	$128,285.44	8,857
9/15/2022	John L. Higgins	CEO	Sell	2,000	$90.00	$180,000.00	367,180
5/13/2022	Matthew W. Foehr	COO	Buy	2,500	$82.76	$206,900.00	173,354
2/28/2022	John W Kozarich	Director	Sell	908	$102.62	$93,178.96

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ligand Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Ashford Capital Management Inc.	310,407	$31.07M	3.9%	-3.7%	1.642%
11/16/2024	Geode Capital Management LLC	428,270	$42.87M	0.0%	+5.5%	2.266%
11/15/2024	Barclays PLC	43,456	$4.35M	0.0%	+20.0%	0.230%
11/15/2024	MML Investors Services LLC	2,094	$0.21M	0.0%	N/A	0.011%
11/15/2024	Castleark Management LLC	67,923	$6.80M	0.3%	+10.7%	0.359%
11/15/2024	Jane Street Group LLC	14,452	$1.45M	0.0%	-35.0%	0.076%
11/15/2024	Wellington Management Group LLP	8,688	$0.87M	0.0%	-39.7%	0.046%
11/15/2024	State Street Corp	707,414	$70.81M	0.0%	+2.7%	3.743%
11/15/2024	Stifel Financial Corp	15,949	$1.60M	0.0%	+16.7%	0.084%
11/15/2024	Janus Henderson Group PLC	1,009,094	$101M	0.1%	+0.0%	5.339%
11/15/2024	HighTower Advisors LLC	5,142	$0.52M	0.0%	+5.5%	0.027%
11/15/2024	Erste Asset Management GmbH	4,300	$0.42M	0.0%	N/A	0.023%
11/14/2024	Edgestream Partners L.P.	34,069	$3.41M	0.1%	N/A	0.180%
11/14/2024	Verition Fund Management LLC	5,961	$0.60M	0.0%	N/A	0.032%
11/14/2024	Captrust Financial Advisors	12,222	$1.22M	0.0%	-3.2%	0.065%
11/14/2024	Martingale Asset Management L P	17,822	$1.78M	0.0%	-11.0%	0.094%
11/14/2024	Isthmus Partners LLC	38,554	$3.86M	0.5%	-20.0%	0.204%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	39,838	$3.99M	0.0%	-13.1%	0.211%
11/14/2024	Public Sector Pension Investment Board	38,747	$3.88M	0.0%	+4.0%	0.205%
11/13/2024	Townsquare Capital LLC	29,813	$2.98M	0.0%	+11.8%	0.158%
11/13/2024	BNP Paribas Financial Markets	4,156	$0.42M	0.0%	-27.6%	0.022%
11/13/2024	FMR LLC	12,749	$1.28M	0.0%	+550.5%	0.067%
11/13/2024	The Manufacturers Life Insurance Company	8,594	$0.86M	0.0%	-1.9%	0.045%
11/13/2024	Loomis Sayles & Co. L P	372,779	$37.31M	0.0%	+44.3%	1.972%
11/13/2024	Fisher Asset Management LLC	59,574	$5.96M	0.0%	+12.4%	0.326%
11/12/2024	Charles Schwab Investment Management Inc.	163,924	$16.41M	0.0%	+5.5%	0.897%
11/9/2024	Intech Investment Management LLC	3,290	$0.33M	0.0%	N/A	0.018%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	26,963	$2.70M	0.0%	+55.9%	0.148%
11/7/2024	Thrivent Financial for Lutherans	15,084	$1.51M	0.0%	+2.2%	0.083%
11/6/2024	Royce & Associates LP	6,090	$0.61M	0.0%	-45.1%	0.033%
11/5/2024	Victory Capital Management Inc.	14,022	$1.40M	0.0%	+79.4%	0.077%
11/4/2024	Lisanti Capital Growth LLC	24,785	$2.48M	0.6%	N/A	0.136%
11/4/2024	Los Angeles Capital Management LLC	7,090	$0.71M	0.0%	-1.8%	0.039%
11/1/2024	Atria Investments Inc	4,685	$0.47M	0.0%	+6.3%	0.026%
11/1/2024	Villere ST Denis J & Co. LLC	474,858	$47.53M	3.9%	-1.9%	2.599%
10/31/2024	Portside Wealth Group LLC	3,100	$0.31M	0.1%	+13.9%	0.017%
10/31/2024	Principal Financial Group Inc.	93,208	$9.33M	0.0%	+5.0%	0.518%
10/30/2024	Amalgamated Bank	5,349	$0.54M	0.0%	+3.7%	0.030%
10/29/2024	Janney Capital Management LLC	4,560	$0.46M	0.0%	-21.8%	0.025%
10/29/2024	F M Investments LLC	134,299	$13.44M	0.5%	-0.3%	0.746%
10/28/2024	Stephens Investment Management Group LLC	618,696	$61.93M	0.8%	-5.1%	3.437%
10/28/2024	Rice Hall James & Associates LLC	312,879	$31.32M	1.7%	+7.0%	1.738%
10/28/2024	Congress Asset Management Co.	604,038	$60.46M	0.4%	+3.0%	3.356%
10/25/2024	China Universal Asset Management Co. Ltd.	3,514	$0.35M	0.0%	+66.4%	0.020%
10/25/2024	abrdn plc	249,269	$24.95M	0.0%	-7.7%	1.385%
10/24/2024	State of Alaska Department of Revenue	10,425	$1.04M	0.0%	+5.1%	0.058%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	661	$64K	0.0%	+23.3%	0.004%
10/23/2024	Louisiana State Employees Retirement System	8,800	$0.88M	0.0%	+3.5%	0.049%
10/23/2024	CWC Advisors LLC.	2,652	$0.27M	0.3%	N/A	0.015%
10/23/2024	Court Place Advisors LLC	13,483	$1.35M	0.4%	-5.1%	0.075%
10/21/2024	Everence Capital Management Inc.	2,760	$0.28M	0.0%	N/A	0.015%
10/19/2024	Allspring Global Investments Holdings LLC	115,480	$11.56M	0.0%	+16.6%	0.642%
10/19/2024	OLD National Bancorp IN	2,279	$0.23M	0.0%	N/A	0.013%
10/18/2024	Chicago Capital LLC	545,821	$54.63M	1.5%	+6.0%	3.032%
10/11/2024	Creative Planning	2,896	$0.29M	0.0%	+4.0%	0.016%
10/11/2024	Woodstock Corp	29,211	$2.92M	0.3%	+0.3%	0.160%
10/10/2024	Essex Investment Management Co. LLC	69,148	$6.92M	1.2%	-2.3%	0.384%
10/10/2024	Kings Path Partners LLC	8,260	$0.83M	0.3%	+20.1%	0.046%
10/5/2024	Handelsbanken Fonder AB	5,358	$0.54M	0.0%	+10.3%	0.030%
8/27/2024	Dana Investment Advisors Inc.	90,056	$7.59M	0.3%	+18.7%	0.500%
8/15/2024	The Manufacturers Life Insurance Company	8,761	$0.74M	0.0%	+4.9%	0.049%
8/15/2024	Dark Forest Capital Management LP	5,043	$0.43M	0.1%	-24.3%	0.028%
8/15/2024	Deerfield Management Company L.P. Series C	7,916	$0.67M	0.0%	N/A	0.044%
8/15/2024	AQR Capital Management LLC	4,924	$0.41M	0.0%	-78.2%	0.027%
8/14/2024	Public Sector Pension Investment Board	37,247	$3.14M	0.0%	+10.9%	0.207%
8/14/2024	ProShare Advisors LLC	3,703	$0.31M	0.0%	-20.0%	0.021%
8/14/2024	Profund Advisors LLC	3,155	$0.27M	0.0%	N/A	0.018%
8/13/2024	Thrivent Financial for Lutherans	14,755	$1.24M	0.0%	-1.6%	0.082%
8/13/2024	Sei Investments Co.	48,065	$4.05M	0.0%	+34.1%	0.267%
8/13/2024	Public Employees Retirement Association of Colorado	2,555	$0.22M	0.0%	-12.2%	0.014%
8/13/2024	Benjamin F. Edwards & Company Inc.	790	$67K	0.0%	N/A	0.004%
8/12/2024	Hsbc Holdings PLC	4,641	$0.39M	0.0%	-11.5%	0.026%
8/12/2024	Amalgamated Bank	5,158	$0.44M	0.0%	-2.8%	0.029%
8/9/2024	Renaissance Technologies LLC	18,200	$1.53M	0.0%	-61.4%	0.101%
8/9/2024	Dimensional Fund Advisors LP	708,624	$59.71M	0.0%	+6.7%	3.937%
8/8/2024	Envestnet Asset Management Inc.	79,612	$6.71M	0.0%	+47.7%	0.442%
8/8/2024	William Blair Investment Management LLC	202,842	$17.09M	0.0%	+7.2%	1.127%
8/8/2024	American Century Companies Inc.	29,167	$2.46M	0.0%	+16.4%	0.162%
8/8/2024	Rice Hall James & Associates LLC	292,475	$24.64M	1.5%	+4.5%	1.625%
8/7/2024	Headlands Technologies LLC	758	$64K	0.0%	+21.7%	0.004%
8/7/2024	Texas Permanent School Fund Corp	13,180	$1.11M	0.0%	-8.1%	0.073%
8/7/2024	Ashton Thomas Private Wealth LLC	1,891	$0.16M	0.0%	N/A	0.011%
8/6/2024	Chicago Capital LLC	514,946	$43.39M	1.3%	+124.3%	2.861%
8/6/2024	Isthmus Partners LLC	48,176	$41K	0.0%	-0.3%	0.268%
8/6/2024	Los Angeles Capital Management LLC	7,220	$0.61M	0.0%	N/A	0.040%
8/5/2024	Arizona State Retirement System	4,708	$0.40M	0.0%	+3.4%	0.026%
8/5/2024	Victory Capital Management Inc.	7,816	$0.66M	0.0%	-13.4%	0.043%
8/1/2024	Rhumbline Advisers	61,332	$5.17M	0.0%	+1.8%	0.341%
8/1/2024	Equitable Trust Co.	4,080	$0.34M	0.0%	N/A	0.023%
7/31/2024	Rothschild Investment LLC	406	$34K	0.0%	N/A	0.002%
7/30/2024	Kings Path Partners LLC	6,880	$0.58M	0.3%	N/A	0.038%
7/29/2024	Principal Financial Group Inc.	88,769	$7.48M	0.0%	-3.6%	0.493%
7/29/2024	Innealta Capital LLC	367	$31K	0.0%	N/A	0.002%
7/29/2024	F M Investments LLC	134,710	$11.35M	0.4%	N/A	0.748%
7/26/2024	Legato Capital Management LLC	14,120	$1.19M	0.2%	+352.7%	0.078%
7/26/2024	Allspring Global Investments Holdings LLC	99,034	$8.35M	0.0%	+16.2%	0.550%
7/26/2024	Bank of New York Mellon Corp	145,990	$12.30M	0.0%	-0.8%	0.811%
7/25/2024	Calamos Advisors LLC	10,847	$0.91M	0.0%	+20.1%	0.060%
7/24/2024	Louisiana State Employees Retirement System	8,500	$0.72M	0.0%	+4.9%	0.047%
7/19/2024	BTC Capital Management Inc.	4,269	$0.36M	0.0%	-7.3%	0.024%

Data available starting January 2016

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.

Today's Range

Now: $111.56

$109.53

$112.00

50 Day Range

MA: $107.71

$97.37

$129.90

52 Week Range

Now: $111.56

$57.00

$129.90

Volume

133,450 shs

Average Volume

136,731 shs

Market Capitalization

$2.11 billion

P/E Ratio

44.45

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top insider investors include:
John L Higgins (Director)
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Matthew E Korenberg (COO)
John W Kozarich (Director)
Octavio Espinoza (CFO)
Stephen L Sabba (Director)
Andrew Reardon (Insider)
Nancy Ryan Gray (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.
Who are the major institutional investors of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top institutional investors include:
Janus Henderson Group PLC — 5.34%
State Street Corp — 3.74%
Stephens Investment Management Group LLC — 3.44%
Congress Asset Management Co. — 3.36%
Chicago Capital LLC — 3.03%
Villere ST Denis J & Co. LLC — 2.60%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.
Which institutional investors are selling Ligand Pharmaceuticals stock?: In the previous quarter, LGND stock was sold by these institutional investors:
Stephens Investment Management Group LLC
abrdn plc
Ashford Capital Management Inc.
Isthmus Partners LLC
Villere ST Denis J & Co. LLC
Jane Street Group LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Wellington Management Group LLP
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
John L Higgins (Director)
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Matthew E Korenberg (COO)
John W Kozarich (Director)
Octavio Espinoza (CFO)
Learn More investors selling Ligand Pharmaceuticals stock.
Which institutional investors are buying Ligand Pharmaceuticals stock?: During the previous quarter, LGND stock was acquired by institutional investors including:
Loomis Sayles & Co. L P
Edgestream Partners L.P.
Chicago Capital LLC
Lisanti Capital Growth LLC
Geode Capital Management LLC
Rice Hall James & Associates LLC
State Street Corp
Congress Asset Management Co.